A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database 72 3

Digital data available（科学技術振興機構）

J-STAGE

A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database

Detailed bibliographic record

Summary, etc.：: <p>Tirzepatide is a novel drug for the treatment of type 2 diabetes mellitus and chronic weight management, and there is an urgent need to explore its...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database
Volume: 72
3
Author/Editor: Li Jie
Xie Jun
Han Yi
Zhang Wei
Wang Yilei
Jiang Zhitao
Author Heading: Li Jie
Xie Jun
Han Yi
Zhang Wei
Wang Yilei
Jiang Zhitao
Publication Date: 2025
Publication Date (W3CDTF): 2025
Periodical title: Endocrine Journal
No. or year of volume/issue: 72 3
Volume: 72
Issue: 3
Pages: 273-283
ISSN (Periodical Title): 0918-8959
1348-4540
ISSN-L (Periodical Title): 0918-8959
Subject Heading: Adverse drug event
FDA Adverse Event Reporting System (FAERS)
Disproportionality analysis
GIP/GLP-1 RA
Tirzepatide
Target Audience: 一般
DOI: 10.1507/endocrj.EJ24-0286
Access Restrictions: インターネット公開
Data Provider (Database): 科学技術振興機構 : J-STAGE
http://www.jstage.jst.go.jp